Does new permanent pacemaker implantation within 30 days following TAVR increase mortality or heart failure rehospitalization in patients undergoing TAVR?
New permanent pacemaker implantation after TAVR does not increase mortality but is associated with increased heart failure rehospitalization and impaired LVEF recovery.
New PPI within 30 days following TAVR was not associated with an increased risk of all-cause or cardiovascular mortality. However, patients with PPI had a higher risk of HF rehospitalization and lack of LVEF improvement.
Zheng et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: